創薬の世界市場予測2018-2026

Inkwood Researchが発行した調査報告書(INKW803017)
◆英語タイトル:GLOBAL DRUG DISCOVERY MARKET FORECAST 2018-2026
◆商品コード:INKW803017
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2108年3月1日
◆ページ数:140
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

Inkwood Researchが調査・発行した本調査レポートでは、創薬の世界市場について調査・分析し、創薬の世界市場動向、市場予測、セグメント別分析、主要地域別分析(アメリカ市場、ヨーロッパ市場、アジア市場)、創薬の世界市場規模、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

KEY FINDINGSPropelled by factors like the low performance of branded drugs as compared to generic drugs and rising spending on healthcare and research, the global drug discovery market is expected to make a leap of 9.73% CAGR, increasing its revenue from $ 36.7 billion to $83.6 billion between the forecast years of 2018-2026.
MARKET INSIGHTS
Technology-wise, the global drug discovery market is segmented into Protein Microarrays, QPCR, Mass Spectrometry, DNA Microarrays, High Throughput Screening, Protein and Nucleic Acid Isolation, Gel Electrophoresis, Chromatography, and Other Technologies. Extensive R&D for new product launches can be viewed as major opportunities for the market to expand.
REGIONAL INSIGHTS
North America, Asia-Pacific, Europe and Rest of World are the geographical segments of this market. By the end of the forecast period, the North American market is anticipated to account for the lion’s share of the global market. The U.S is expected to be a major contributor to this region, driven by high healthcare spending and growing lifestyle oriented diseases. Also, the Asia-Pacific market is predicted to register the fastest growth driven by high investments and growing R&D.
COMPETITIVE INSIGHTS
Noted players in the global drug discovery market include Bayer Ag, AstraZeneca Plc, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd, Eli Lily, GlaxoSmithKline Llc, Merck & Co. Inc, Sanofi and Pfizer Inc.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. HIGH PREVALENCE RATES OF MAJOR HEALTH DISORDERS
3.2.2. NORTH AMERICA HAS THE HIGHEST MARKET SHARE
3.2.3. ASIA PACIFIC IS THE FASTEST GROWING REGION
3.2.4. IMPLEMENTATION OF DRUG DISCOVERY PROGRAMS
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. AGING POPULATION
4.1.2. BRANDED DRUGS ARE OUTPERFORMING DUE TO HIGH COST AS COMPARED TO GENERIC DRUGS
4.1.3. SPENDING ON HEALTHCARE HAS BEEN INCREASING
4.1.4. GLOBAL INCREASE IN LIFESTYLE ORIENTED DISEASES & FATALITIES
4.2. MARKET RESTRAINTS
4.2.1. GOVERNMENT REGULATIONS DELAYING THE PROCESSES
4.2.2. DELAY IN PRODUCT LAUNCHES
4.2.3. POOR ACCESS TO THE HEALTHCARE SERVICES IN DEVELOPING MARKETS
4.2.4. MARKET IS SHIFTING FROM BRANDED TO GENERIC DRUGS
4.3. MARKET CHALLENGES
4.3.1. COST BARRIER FOR LOCAL PEOPLE IN EMERGING ECONOMIES
4.4. MARKET OPPORTUNITIES
4.4.1. EXTENSIVE R&D FOR NEW PRODUCT LAUNCHES
5. MARKET SEGMENTATION
5.1. MARKET BY TECHNOLOGY 2018-2026
5.1.1. QPCR
5.1.2. DNA MICROARRAYS
5.1.3. PROTEIN MICROARRAYS
5.1.4. HIGH-THROUGHPUT SCREENING
5.1.5. MASS SPECTROMETRY
5.1.6. GEL ELECTROPHORESIS
5.1.7. CHROMATOGRAPHY
5.1.8. PROTEIN AND NUCLEIC ACID ISOLATION
5.1.9. OTHER TECHNOLOGIES
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREATS OF NEW ENTRANTS(LOW)
6.1.2. COMPETITIVE RIVALRY (HIGH)
6.1.3. BARGAINING POWER OF BUYERS (MEDIUM)
6.1.4. BARGAINING POWER OF SUPPLIERS (LOW)
6.1.5. THREAT OF SUBSTITUTE PRODUCTS (HIGH)
6.2. VALUE CHAIN ANALYSIS
6.3. KEY EXCERPTS OF THE STUDY
6.3.1. RELAXATION IN THE REGULATIONS BY THE GOVERNMENT WHICH STOPS RESEARCHERS FROM DOING RESEARCH.
6.3.2. MARKET LEADERS SHOULD OPEN UP THEIR BRANCHES AND RESEARCH LABS IN EMERGING MARKETS.
6.4. PESTLE ANALYSIS
6.5. OPPORTUNITY MATRIX
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES (U.S.)
7.1.2. CANADA
7.2. EUROPE
7.2.1. UNITED KINGDOM (UK)
7.2.2. FRANCE
7.2.3. GERMANY
7.2.4. SPAIN
7.2.5. ITALY
7.2.6. REST OF EUROPE (ROE)
7.3. ASIA PACIFIC
7.3.1. INDIA
7.3.2. CHINA
7.3.3. JAPAN
7.3.4. KOREA
7.3.5. AUSTRALIA
7.3.6. REST OF ASIA-PACIFIC (ROAPAC)
7.4. REST OF THE WORLD (ROW)
8. COMPANY PROFILES
8.1. ASTRAZENECA PLC
8.1.1. COMPANY OVERVIEW
8.1.2. PRODUCT PORTFOLIO
8.1.3. SWOT ANALYSIS
8.1.4. STRATEGIC INITIATIVES
8.2. BAYER AG
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SWOT ANALYSIS
8.2.4. STRATEGIC INITIATIVES
8.3. BOEHRINGER INGELHEIM
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SWOT ANALYSIS
8.4. ELI LILY
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. SWOT ANALYSIS
8.4.4. STRATEGIC INITIATIVES
8.5. F. HOFFMANN-LA ROCHE LTD
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. SWOT ANALYSIS
8.5.4. STRATEGIC INITIATIVES
8.6. GLAXOSMITHKLINE LLC
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SWOT ANALYSIS
8.6.4. STRATEGIC INITIATIVES
8.7. JOHNSON AND JOHNSON
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SWOT ANALYSIS
8.7.4. STRATEGIC INITIATIVES
8.8. MERCK & CO. INC.
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SWOT ANALYSIS
8.8.4. STRATEGIC INITIATIVES
8.9. PFIZER, INC.
8.9.1. COMPANY OVERVIEW
8.9.2. SWOT ANALYSIS
8.9.3. STRATEGIC INITIATIVES
8.10. SANOFI
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. SWOT ANALYSIS
8.10.4. STRATEGIC INITIATIVES

TABLE LIST
TABLE 1 GLOBAL DRUG DISCOVERY MARKET BY GEOGRAPHY 2018-2026 (IN $MILLION)
TABLE 2 FACT SHEETS OF GLOBAL FATALITIES
TABLE 3 GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2018-2026
TABLE 4 GLOBAL DRUG DISCOVERY MARKET IN QPCR BY GEOGRAPHY 2018-2026 (IN $MILLION)
TABLE 5 GLOBAL DRUG DISCOVERY MARKET IN DNA MICROARRAYS BY GEOGRAPHY 2018-2026 (IN $MILLION)
TABLE 6 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN MICROARRAYS, BY GEOGRAPHY 2018-2026(IN $MILLION)
TABLE 7 GLOBAL DRUG DISCOVERY MARKET IN HIGH THROUGHPUT SCREENING, BY GEOGRAPHY 2018-2026(IN $MILLION)
TABLE 8 GLOBAL DRUG DISCOVERY MARKET IN MASS SPECTROMETRY, BY GEOGRAPHY 2018-2026 (IN $MILLION)
TABLE 9 GLOBAL DRUG DISCOVERY MARKET IN GEL ELECTROPHORESIS, BY GEOGRAPHY 2018-2026, (IN $MILLION)
TABLE 10 GLOBAL DRUG DISCOVERY MARKET IN CHROMATOGRAPHY, BY GEOGRAPHY 2018-2026 (IN $MILLION)
TABLE 11 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN AND NUCLEIC ACID ISOLATION, BY GEOGRAPHY 2018-2026 (IN $MILLION)
TABLE 12 GLOBAL DRUG DISCOVERY MARKET IN OTHER TECHNOLOGIES MARKET, BY GEOGRAPHY 2018-2026 (IN $MILLION)
TABLE 13 GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY 2018-2026 (IN $MILLION)
TABLE 14 NORTH AMERICA DRUG DISCOVERY MARKET, 2018-2026 (IN $ MILLION)
TABLE 15 EUROPE DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
TABLE 16 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE LIST
FIGURE 1 GLOBAL DRUG DISCOVERY MARKET 2018-2026 (IN $MILLION)
FIGURE 2 GLOBAL DRUG DISCOVERY MARKET IN QPCR 2018-2026 (IN $MILLION)
FIGURE 3 GLOBAL DRUG DISCOVERY MARKET IN DNA MICROARRAYS 2018-2026 (IN $MILLION)
FIGURE 4 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN MICROARRAYS 2018-2026 (IN $MILLION)
FIGURE 5 GLOBAL DRUG DISCOVERY MARKET IN HIGH THROUGHPUT SCREENING 2018-2026 (IN $MILLION)
FIGURE 6 GLOBAL DRUG DISCOVERY MARKET IN MASS SPECTROMETRY 2018-2026 (IN $MILLION)
FIGURE 7 GLOBAL DRUG DISCOVERY MARKET IN GEL ELECTROPHORESIS 2018-2026 (IN $MILLION)
FIGURE 8 GLOBAL DRUG DISCOVERY MARKET IN CHROMATOGRAPHY 2018-2026 (IN $MILLION)
FIGURE 9 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN AND NUCLEIC ACID ISOLATION 2018-2026 (IN $MILLION)
FIGURE 10 GLOBAL DRUG DISCOVERY MARKET IN OTHER TECHNOLOGIES 2018-2026 (IN $MILLION)
FIGURE 11 GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY 2018-2026 (IN $MILLION)
FIGURE 12 NORTH AMERICA DRUG DISCOVERY MARKET, 2018-2026 (IN $ MILLION)
FIGURE 13 UNITED STATES DRUG DISCOVERY MARKET, 2018-2026 (IN $ MILLION)
FIGURE 14 CANADA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 15 EUROPE DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 16 UNITED KINGDOM DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 17 FRANCE DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 18 GERMAN DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 19 SPAIN DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 20 ITALY DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 21 REST OF EUROPE (ROE) DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 22 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 23 INDIA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 24 CHINA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 25 JAPAN DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 26 KOREA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 27 AUSTRALIA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 28 REST OF ASIA-PACIFIC (ROAPAC) DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)
FIGURE 29 REST OF THE WORLD (ROW) DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)



【レポートのキーワード】

創薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 創薬の世界市場予測2018-2026(GLOBAL DRUG DISCOVERY MARKET FORECAST 2018-2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆